Search results
Free COVID Home Test Kits Are Still Available: Here's How to Get Them
CNET· 5 days agoIf you have any COVID symptoms, you should get tested as soon as possible. Luckily, there are plenty of free COVID tests and treatments still available. Recently, the Federal Government halted ...
COVID-19 Tests in the Workplace
The National Law Review· 7 days agoThe U.S. Equal Employment Opportunity Commission (EEOC) has updated its Technical Assistance Guidance to clarify that employers may administer and/or require COVID-19 testing as a gateway mechanism ...
New York Secures $1M Settlement With Northwell Health Related to COVID-19 Testing Charges | JD Supra
JD Supra· 5 days agoOn April 12, New York Attorney General (AG) Letitia James announced that her office has reached a settlement with Northwell Health, New York’s largest health care network, related to allegations ...
Abbott Diagnostics Q1 Revenues Down 18 Percent, Total Revenues up 2 Percent
GenomeWeb News· 6 days agoAbbott on Wednesday announced that its Q1 2024 Diagnostics revenues declined 18 percent year over year as a result of declining COVID-19 testing sales. For the three months ended March 31, Abbott ...
White House expands its global pandemic prevention efforts
Scripps News via AOL· 6 days agoA lab technician performs COVID-19 testing The White House plans to expand coordination and support...
Abbott beats estimates, reports a 2.2% rise in Q1 sales | Invezz
Invezz· 6 days agoAbbott Laboratories on April 17 reported a 2.2% rise of $10 billion in its 2024 first-quarter sales...
Should You Buy Exact Sciences (EXAS) Ahead of Q1 Earnings?
Zacks via Yahoo Finance· 17 hours agoExact Sciences' (EXAS) first-quarter 2024 performance is expected to include gains from robust...
Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract
Zacks via Yahoo Finance· 6 days agoAbbott Laboratories ABT reported first-quarter 2024 adjusted earnings per share (EPS) of 98 cents,...
Unlocking Q1 Potential of Quest Diagnostics (DGX): Exploring Wall Street Estimates for Key Metrics
Zacks via Yahoo Finance· 20 hours agoLooking beyond Wall Street's top -and-bottom-line estimate forecasts for Quest Diagnostics (DGX),...
QDEL INVESTOR ALERT: Securities Fraud Class Action Filed After QuidelOrtho (QDEL) Reports Disastrous...
Morningstar· 11 hours agoSAN FRANCISCO, April 22, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges QuidelOrtho Corporation (NASDAQ: QDEL) investors who suffered substantial losses to submit your losses now. Class Period: Feb. 18, 2022 – Apr. 1, 2024Lead Plaintiff Deadline